DiaMex GmbH
Acquisition in 2024
DiaMex provides a comprehensive portfolio of Manufacturer-Independent Quality Controls, also called 3rd Party Controls.
Kova International
Acquisition in 2023
Kova International is a manufacturer specializing in quality control products and plastic assemblies for the clinical diagnostic laboratory sector. The company focuses on urinalysis products designed for the medical laboratory market, offering a range of sample collection tubes, caps, and slides specifically for urine dipstick chemistry, confirmatory and pregnancy tests, as well as microscopic urinalysis. Additionally, Kova International provides urine chemistry test strips and readers to facilitate microscopic sediment analysis, catering to the needs of laboratories in enhancing diagnostic accuracy and efficiency.
Rapid Genomics
Acquisition in 2022
Rapid Genomics specializes in providing tailored genetic and genomic solutions aimed at enhancing agricultural practices. The company develops innovative applications that focus on improving germplasm and breeding stock for crops and livestock. By leveraging advanced genetic research, Rapid Genomics seeks to optimize crop yields, promote healthier livestock, and contribute to sustainable bioenergy, food, and fiber production. Their technology supports various agricultural stakeholders in achieving better outcomes, ultimately fostering advancements that benefit both the environment and society.
Technopath Clinical Diagnostics
Acquisition in 2021
Technopath Clinical Diagnostics is a company focused on developing and manufacturing quality control materials and software specifically for clinical laboratories. It produces independent quality control products that cater to both in vitro and clinical diagnostic applications. Additionally, Technopath offers a software platform designed to automate the handling and management of quality control data, enhancing the efficiency of laboratories in meeting accreditation requirements. Through its innovative products and services, the company supports laboratories in achieving accurate and reliable diagnostic results.
MBH Analytical
Acquisition in 2018
MBH Analytical Ltd, founded in 1973 and based in Barnet, United Kingdom, specializes in the manufacture and supply of metal alloy reference materials for spectroscopic and spectrochemical analysis. As a leading global producer, MBH Analytical provides a comprehensive range of Certified Reference Materials that are utilized in various industries including metallurgical test houses, foundries, and automotive sectors. The company’s catalog includes over 1,400 reference materials, a result of its integration with the ARMI product range following its acquisition by LGC Limited in December 2018. MBH Analytical is committed to meeting the diverse needs of laboratories worldwide and can source additional materials through its extensive network when necessary.
SeraCare
Acquisition in 2018
SeraCare Life Sciences, Inc. is a provider of products and services that support the discovery, development, and production of diagnostics and therapeutics for both human and animal use. The company operates through two main segments: Diagnostic and Biopharmaceutical Products, and BioServices. Its Diagnostic and Biopharmaceutical Products segment offers controls and panels for infectious disease testing, reagents, and bioprocessing products essential for drug and vaccine development. This includes diagnostic intermediates, cell culture additives, therapeutic grade albumin, and purified human cells. The BioServices segment provides biorepository services, sample processing, testing for research and clinical trials, and contract research support in various fields, including molecular biology and virology. SeraCare serves a diverse clientele, including laboratories, blood banks, IVD manufacturers, government agencies, and academic institutions, primarily through direct sales and independent distributors across the United States, Europe, and Asia. Founded in 1984 and headquartered in Milford, Massachusetts, SeraCare operates as a subsidiary of LGC Standards Ltd. after being taken private in 2012.
Berry & Associates
Acquisition in 2018
Berry & Associates, Inc. is a Dexter, Michigan-based company that specializes in the development and supply of stable isotope-labeled nucleosides and phosphoramidites, along with specialty oligo reagents. Founded in 1989, the company employs a team of 14 people and has expanded its offerings since acquiring Icon Isotopes in 2015, which enabled it to provide stable isotope research compounds and gases. Berry & Associates manufactures a diverse range of nearly 200 phosphoramidites and solid-phase-linked monomers, catering to the needs of contract manufacturing organizations, pharmaceuticals, clinical diagnostics firms, and academic research institutions. The company also engages in collaborative projects with universities, enhancing its position in the market for specialty chemicals and oligonucleotide synthesis.
BioAutomation Systems
Acquisition in 2018
Since 1999, BioAutomation has served the biotechnology industry with automation solutions to assist in research and development. Their strength is their ability to design, deliver and service solutions that are tailored to their customers applications. Their oligonucleotide synthesizers provide scientists and researchers in the biotech field specialized tools capable of adapting to changing requirements. These products come in a variety of configurations to serve the needs of their customers.
Lucigen
Acquisition in 2018
Lucigen Corporation specializes in providing products and services for DNA and RNA cloning, sequencing, amplification, and protein expression. Founded in 1998 and based in Middleton, Wisconsin, the company offers a comprehensive range of solutions including long mate pair library kits, DNA sample preparation kits, and various cloning and expression kits. Its portfolio encompasses PCR and amplification solutions, competent cells for cloning and phage display, and a variety of enzymes. Additionally, Lucigen provides cloning kits and vectors tailored for different applications, as well as accessory kits for DNA manipulation. The company also offers genome closure services and advanced genomic technologies to support life science researchers in their work. Lucigen Corporation was formerly known as Microgen Corporation and became a subsidiary of LGC Limited in 2018.
Link Technologies
Acquisition in 2017
Link Technologies Ltd. specializes in the custom and contract manufacturing of specialty products for oligonucleotides. The company provides a wide range of reagents essential for DNA, RNA, LNA, and PNA synthesis and modification, including modified nucleosides, phosphoramidites, and various forms of nucleotides. Additionally, Link Technologies offers solvents, solid supports for DNA and RNA synthesis, and peptide nucleic acids. The company also provides an array of services such as reverse synthesis, backbone modification, and bioconjugation, along with analytical methods and product testing. With over 25 years of experience in nucleotide chemistry, Link Technologies serves both commercial and academic researchers in fields like gene sequencing, gene therapy, diagnostics, and molecular biology. Founded in 1989 and based in Bellshill, United Kingdom, Link Technologies operates as a subsidiary of LGC Limited.
Axolabs
Acquisition in 2017
Axolabs GmbH is a preclinical research organization specializing in nucleic acid therapeutics, particularly in the oligonucleotide sector. Established in 2007 and based in Kulmbach, Germany, the company offers a range of tailored services that encompass nucleic acid drug discovery, preclinical research and development, oligonucleotide synthesis, and various analytical services. Additionally, Axolabs provides consultancy, target validation, and assessments of delivery technologies. The company, which was formerly known as Roche Kulmbach GmbH, leverages over a decade of expertise in the field, drawing on the foundational knowledge from the former Roche Center of Excellence for RNA Therapeutics. Axolabs operates as a subsidiary of LGC Limited and has developed strategic alliances to enhance its service offerings in the rapidly evolving market for therapeutic nucleic acids.
API Food Quality
Acquisition in 2017
API Food Quality, known for its innovative solutions and technical excellence, offered the world’s first accredited proficiency testing program for six non-O157 Shiga toxin-producing E. coli (STEC) adulterants. Among the largest proficiency testing providers globally, it serves over 1,000 food laboratories in 30 countries.
BRC Global Standards
Acquisition in 2016
BRC Global Standards is a leading provider of safety and quality standards programs for the food industry, covering manufacturing, packaging, storage, and distribution. With over 24,000 certified suppliers across 130 countries, BRC Global Standards offers a globally recognized certification that ensures adherence to quality, safety, and operational criteria. Through an accredited network of certification bodies, BRC Global Standards helps manufacturers meet legal requirements and ensures consumer protection throughout the supply chain.
Prime Synthesis
Acquisition in 2016
Prime Synthesis, Inc. is a developer and manufacturer of DNA synthesis materials, primarily serving the biomedical research sector. Established in 1988, the company specializes in the production of Controlled Pore Glass (CPG) supports for oligonucleotide synthesis, which are essential for genomic research and therapeutic applications. Based in Aston, Pennsylvania, Prime Synthesis operates a 20,000 square-foot facility that houses administrative offices, production areas, and research laboratories. The company's core offerings include ancillary reagents, reagent kits, CE phosphoramidites, oligo purification products, and molecular traps. Prime Synthesis has established cooperative partnerships with local universities, granting access to advanced microscopy and spectroscopy equipment, and fostering collaboration with specialists in biomedical, chemistry, and materials science. In 2016, the company was acquired by LGC, enhancing its capabilities and integrating its products into a broader portfolio in nucleic acid chemistry.
o2si smart solutions
Acquisition in 2016
o2si smart solutions, LLC is a manufacturer of organic and inorganic reference materials, providing essential calibration standards for various industries, including environmental, petroleum, clinical, food, industrial hygiene, and pharmaceuticals. Established in 1997 and based in Charleston, South Carolina, the company specializes in custom, made-to-order standards that are competitively priced and offered with quick turnaround times. Its product range includes volatile and semi-volatile organic mixes, pesticide and PCB mixes, single component organic solutions, as well as ion chromatography standards and multi-element inorganic mixes. o2si has built a reputation for superior technical expertise and exceptional customer service, enabling it to expand into new markets and become a recognized leader in the environmental standards and calibration sectors. The company distributes its products worldwide, ensuring accessibility for a diverse clientele.
Douglas Scientific
Acquisition in 2016
Douglas Scientific LLC, based in Alexandria, Minnesota, specializes in designing and manufacturing laboratory instruments and automation solutions. Founded in 2009 and incorporated as a separate entity in 2010, the company is recognized for its patented Array Tape technology, which consists of a continuous polymer strip with micro wells used for laboratory testing. This innovation allows laboratories to efficiently process billions of genetic samples and chemical compounds, significantly enhancing screening speed and reducing costs. Douglas Scientific's product offerings include a range of automated instruments such as the IntelliQube, Nexar, Soellex, and Araya, which optimize various laboratory processes like liquid handling, thermal cycling, and fluorescence detection. The company also provides custom automation services and software solutions for assay monitoring and management. With a workforce of over 100 professionals, Douglas Scientific is committed to advancing scientific research in fields such as plant genomics, animal health, human diagnostics, and pharmaceuticals.
Maine Standards Company
Acquisition in 2015
Maine Standards Company is the provider of calibration verification materials for clinical laboratories.
Thistle QA
Acquisition in 2015
Thistle QA is a proficiency testing service provider based in Bryanston, South Africa. The company offers a comprehensive range of over 35 proficiency testing schemes aimed at various industries. Thistle QA specializes in delivering high-quality testing services to participants, ensuring they meet industry standards and improve their operational efficiencies.
Biosearch Technologies
Acquisition in 2015
Biosearch Technologies, Inc. is a Petaluma, California-based company founded in 1993, specializing in the design and manufacture of nucleic acid-based products that enhance genomic research and applications. The company offers a range of products including ValuPanel Reagents for research, Stellaris RNA FISH probes for detecting and quantifying individual mRNA molecules in fixed samples, and custom oligonucleotides. Additionally, Biosearch provides fluorogenic probes and primers, along with labeling reagents such as acids and active esters for post-synthesis labeling of DNA, proteins, and peptides. Its offerings also include immunochemicals featuring protein and fluorophore conjugates. Biosearch Technologies markets its products through a network of distributors both domestically and internationally, and it is ISO 9001:2008 certified, underscoring its commitment to quality in the biotechnology sector.
HFL Sport Science
Acquisition in 2010
HFL Sport Science is the world’s largest independent provider of drug surveillance, doping control and research activities to human and equine sports. The acquisition of HFL will extend and complement LGC’s current analytical service offerings.